CellaVision, which develops and sells products for routine analysis of blood and
other body fluids in health care, has received clearance by the FDA to market
and sell its application for analysis of body fluids, for use with the company's
cell morphology system for medium-sized laboratories, the CellaVision® DM1200.
By using the application, clinical laboratories are able to analyze spinal
fluid, synovial fluid and pleural fluid among other body fluids.

To assess blood cells in body fluid samples is a complicated procedure in
clinical laboratories, requiring years of experience. CellaVision® Body Fluid
Application helps to streamline the process and to increase the quality of test
results.

"We see a great need among our customers for the type of functions that
CellaVision's automated products can now offer. To analyze blood and other body
fluids quickly and effectively is an ideal solution for many laboratories,
especially as the supply of qualified Medical Technologists is in...